By integrating the transcriptome data from clinical specimens, in vitro, and in vivo approaches, we unveiled the importance and therapeutic potential of the regulatory mechanisms of CXCR7 on CXCL12 in glioblastoma cells, which consequently affected GAM induction and T-cell alteration. This evidence concerns the gene CXCL12 and glioblastoma.